Assignee
PROMETHEUS LAB INC
US·13 granted patents·14 pending applications·295 citations·filing 1997–2012
Top patents by PatentIndex Score
27 records- 0192US7908091B2Methods of predicting and monitoring tyrosine kinase inhibitor therapyPROMETHEUS LAB INC·Filed 2007·Granted Mar 15, 2011·13 cites·19 claims
- 0292US6986995B2Methods of diagnosing liver fibrosisPROMETHEUS LAB INC·Filed 2002·Granted Jan 17, 2006·59 cites·63 claims
- 0391US7873479B2Methods of diagnosing inflammatory bowel diseasePROMETHEUS LAB INC·Filed 2006·Granted Jan 18, 2011·16 cites·33 claims
- 0487US7695908B2Methods for predicting methotrexate polyglutamate levels using pharmacogeneticsPROMETHEUS LAB INC·Filed 2005·Granted Apr 13, 2010·5 cites·20 claims
- 0586US7943328B1Method and system for assisting in diagnosing irritable bowel syndromePROMETHEUS LAB INC·Filed 2007·Granted May 17, 2011·12 cites·20 claims
- 0686US6218129B1Inflammatory bowel disease first step assay systemPROMETHEUS LAB INC·Filed 1998·Granted Apr 17, 2001·85 cites·24 claims
- 0785US7759079B2Methods of diagnosing inflammatory bowel diseasePROMETHEUS LAB INC·Filed 2005·Granted Jul 20, 2010·24 cites·21 claims
- 0884US7670764B2Methods of diagnosing tissue fibrosisPROMETHEUS LAB INC·Filed 2004·Granted Mar 2, 2010·17 cites·46 claims
- 0978US6921667B2Methods for direct detection of individual methotrexate metabolitesPROMETHEUS LAB INC·Filed 2003·Granted Jul 26, 2005·13 cites·77 claims
- 1077US6576438B2Method of determining thiopurine methyltransferase activityPROMETHEUS LAB INC·Filed 2001·Granted Jun 10, 2003·13 cites·7 claims
- 1174US7582282B2Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogeneticsPROMETHEUS LAB INC·Filed 2004·Granted Sep 1, 2009·5 cites·28 claims
- 1271US7138250B2Method of determining thiopurine methyltransferase activityPROMETHEUS LAB INC·Filed 2003·Granted Nov 21, 2006·1 cites·14 claims
- 1371US2010203507A1Methods of predicting methotrexate efficacy and toxicityPROMETHEUS LAB INC·Filed 2008·Application pending·0 cites
- 1471US2010203508A1Methods of predicting methotrexate efficacy and toxicityPROMETHEUS LAB INC·Filed 2008·Application pending·0 cites
- 1569US2008182280A1Methods of diagnosing inflammatory bowel diseasePROMETHEUS LAB INC·Filed 2007·Application pending·0 cites
- 1666US2013143215A1Methods of Predicting Methotrexate Efficacy and ToxicityPROMETHEUS LAB INC·Filed 2012·Application pending·0 cites
- 1765US6183951B1Methods of diagnosing clinical subtypes of crohn's disease with characteristic responsiveness to anti-Th1 cytokine therapyPROMETHEUS LAB INC·Filed 1997·Granted Feb 6, 2001·32 cites·37 claims
- 1864US2006286571A1Methods of predicting methotrexate efficacy and toxicityPROMETHEUS LAB INC·Filed 2006·Application pending·0 cites
- 1956US2007093497A1Methotrexate compliance packagingPROMETHEUS LAB INC·Filed 2006·Application pending·0 cites
- 2054US2008085524A1Methods for diagnosing irritable bowel syndromePROMETHEUS LAB INC·Filed 2007·Application pending·0 cites
- 2152US2010203539A1Methods for predicting methotrexate polyglutamate levels using pharmacogeneticsPROMETHEUS LAB INC·Filed 2010·Application pending·0 cites
- 2252US2011244465A1Methods of predicting and monitoring tyrosine kinase inhibitor therapyPROMETHEUS LAB INC·Filed 2011·Application pending·0 cites
- 2350US2010094560A1Methods for diagnosing irritable bowel syndromePROMETHEUS LAB INC·Filed 2008·Application pending·0 cites
- 2450US2010317022A1Methods of diagnosing tissue fibrosisPROMETHEUS LAB INC·Filed 2010·Application pending·0 cites
- 2547US2010129838A1Methods for prediction of inflammatory bowel disease (ibd) using serologic markersPROMETHEUS LAB INC·Filed 2009·Application pending·0 cites
- 2644US2006216726A1Method for optimizing thiopurine efficacy and toxicity using mass spectrometryPROMETHEUS LAB INC·Filed 2005·Application pending·0 cites
- 2739US2006154276A1Methods of diagnosing inflammatory bowel diseasePROMETHEUS LAB INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PROMETHEUS LAB INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →